Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Milestone Pharmaceuticals (MIST) Earnings Date, Estimates & Call Transcripts

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Free MIST Stock Alerts
$1.74
-0.01 (-0.57%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(Mar. 21)
-$0.32 Missed By -$0.02
Consensus EPS
(Mar. 21)
-$0.30
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MIST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MIST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Milestone Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.30)($0.30)($0.30)
Q2 20241($0.13)($0.13)($0.13)
Q3 20241($0.13)($0.13)($0.13)
Q4 20241($0.14)($0.14)($0.14)
FY 20244($0.70)($0.70)($0.70)

MIST Earnings Date and Information

Milestone Pharmaceuticals last posted its quarterly earnings data on March 21st, 2024. The reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.02. Milestone Pharmaceuticals has generated ($1.25) earnings per share over the last year (($1.25) diluted earnings per share). Earnings for Milestone Pharmaceuticals are expected to decrease in the coming year, from ($0.79) to ($1.22) per share. Milestone Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

Milestone Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
Estimated)		------- 
3/21/2024Q4 2023($0.30)($0.32)($0.02)($0.32)--
11/13/2023Q3 2023($0.38)($0.35)+$0.03($0.35)--
8/10/2023Q2 2023($0.39)($0.37)+$0.02($0.37)--
5/11/2023Q1 2023($0.38)($0.35)+$0.03($0.35)-$1.00 million
3/29/2023Q4 2022($0.35)($0.31)+$0.04($0.31)$3.50 million$3.50 million
11/10/2022Q3 2022($0.41)($0.34)+$0.07($0.34)-$1.50 million
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
8/10/2022Q2 2022($0.36)($0.39)($0.03)($0.39)--
5/12/2022Q1 2022($0.39)($0.33)+$0.06($0.33)--    
3/24/2022Q4 2021-($0.40)($0.40)($0.40)--
11/12/2021Q3 2021($0.38)($0.34)+$0.04($0.34)--
8/11/2021Q2 2021($0.26)$0.02+$0.28$0.02-$15.00 million

Milestone Pharmaceuticals Earnings - Frequently Asked Questions

When is Milestone Pharmaceuticals's earnings date?

Milestone Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on MIST's earnings history.

Did Milestone Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Milestone Pharmaceuticals (NASDAQ:MIST) missed the analysts' consensus estimate of ($0.30) by $0.02 with a reported earnings per share (EPS) of ($0.32). Learn more on analysts' earnings estimate vs. MIST's actual earnings.

How much revenue does Milestone Pharmaceuticals generate each year?

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded annual revenue of $1 million.

How much profit does Milestone Pharmaceuticals generate each year?

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded net income of -$59.69 million. MIST has generated -$1.25 earnings per share over the last four quarters.

What is Milestone Pharmaceuticals's EPS forecast for next year?

Milestone Pharmaceuticals's earnings are expected to decrease from ($0.79) per share to ($1.22) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MIST) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Urgent Nvidia Warning
Altimetry
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Global crypto currency reset (41 major banks signed up)
Stansberry Research
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing